Search results for "vaccines"

showing 10 items of 554 documents

Spontaneous Regression of a Recalcitrant Wart after Bivalent Papillomavirus Vaccination

2017

business.industryCross ProtectionPapillomavirus InfectionsRemission SpontaneousVirologyBivalent (genetics)Vaccination030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicine030220 oncology & carcinogenesisPediatrics Perinatology and Child HealthHumansMedicineFemalePapillomavirus VaccinesWartsHuman papillomavirusChildbusinessPapillomaviridaeThe Journal of Pediatrics
researchProduct

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1996

Background Concern about both safety and efficacy has made the use of whole-cell pertussis vaccines controversial. In some European countries, including Italy, the rate of vaccination against pertussis is low. Methods We conducted a double-blind trial in Italy in which infants were randomly assigned to vaccination at two, four, and six months of age with an acellular pertussis vaccine together with diphtheria and tetanus toxoids (DTP); a DTP vaccine containing whole-cell pertussis (manufactured by Connaught Laboratories); or diphtheria and tetanus toxoids without pertussis (DT). The acellular DTP vaccine was either one containing filamentous hemagglutinin, pertactin, and pertussis toxin ina…

business.industryDiphtheriaFilamentous haemagglutinin adhesinGeneral Medicinemedicine.diseasePertussis toxincomplex mixturesVirologyVaccinationImmunologymedicineDiphtheria-Tetanus VaccinePertactinbusinessDiphtheria-Tetanus-acellular Pertussis VaccinesWhooping coughNew England Journal of Medicine
researchProduct

Vaccination Status and Attitudes towards Vaccines in a Cohort of Patients with Celiac Disease.

2022

(1) Background: The identification of vaccination status and attitudes towards vaccines among celiac disease (CD) patients is of great importance, but it has not yet been investigated. The aim of this study was to investigate coverage against vaccine-preventable diseases (VPDs), attitudes towards vaccinations, and its determinants among CD patients. (2) Methods: An anonymous web-based validated questionnaire was sent to a mailing list of CD adult patients. Patients were asked to self-report their previous vaccinations and attitudes towards vaccinations, which were defined as positive, negative, and partially positive/negative. The influencing factors towards vaccinations were investigated, …

celiac disease coeliac disease hyposplenism vaccine hesitancy vaccinesSettore BIO/13 - Biologia Applicatahyposplenismvaccine hesitancyvaccinesvaccines; vaccine hesitancy; celiac disease; coeliac disease; hyposplenismcoeliac diseaseceliac diseaseVaccines
researchProduct

Synthesis of a MUC1-glycopeptide-BSA conjugate vaccine bearing the 3'-deoxy-3'-fluoro-Thomsen-Friedenreich antigen.

2011

A novel MUC1-glycopeptide–BSA conjugate vaccine with a specifically fluorinated Thomsen–Friedenreich antigen side chain at Thr6 was prepared. Preliminary immunological experiments reveal specific binding of the tumor-associated glycopeptide antigen analog by anti-MUC1-mouse antibodies.

digestive systemCatalysisMiceAntigenConjugate vaccineMaterials ChemistryAnimalsAntigens Tumor-Associated Carbohydrateskin and connective tissue diseasesneoplasmsMUC1Vaccines ConjugatebiologyThomsen-Friedenreich AntigenChemistryMucin-1Metals and AlloysGlycopeptidesSerum Albumin BovineGeneral ChemistryMolecular biologybiological factorsdigestive system diseasesGlycopeptideSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsCeramics and Compositesbiology.proteinCattleAntibodyChemical communications (Cambridge, England)
researchProduct

Combination vaccines containing DTPa–Hib: impact of IPV and coadministration of CRM197 conjugates

2008

Vaccination with diphtheria-tetanus-acellular pertussis (DTPa)-Haemophilus influenzae type b (Hib) combinations generally elicits anti-polyribosyl-ribitol-phosphate (PRP) antibody concentrations of more than 0.15 microg/ml, a criterion that is linked to the protection of infants against Hib disease. In the UK, vaccination with DTPa3-Hib elicited atypically low anti-PRP antibody levels and was associated with breakthrough Hib cases. While the absence of a toddler booster is considered to be a key factor explaining the lowered control of Hib disease, we propose that the coadministration of serogroup C Neisseria meningitidis conjugate vaccine (MenC)-CRM197, which coincided with the introductio…

health care facilities manpower and servicesImmunologyDiphtheria-Tetanus-acellular Pertussis Vaccinesmedicine.disease_causecomplex mixturesBacterial ProteinsAntigenConjugate vaccineImmunityDrug DiscoveryHumansMedicineDiphtheria-Tetanus-acellular Pertussis VaccinesHaemophilus VaccinesPharmacologybusiness.industryNeisseria meningitidisToxoidHepatitis Bbacterial infections and mycosesmedicine.diseaseVirologyUnited Kingdomcarbohydrates (lipids)VaccinationPoliovirus Vaccine InactivatedImmunologybacteriaMolecular MedicinebusinessExpert Review of Vaccines
researchProduct

How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells

2022

Vaccination, being able to prevent millions of cases of infectious diseases around the world every year, is the most effective medical intervention ever introduced. However, immunosenescence makes vaccines less effective in providing protection to older people. Although most studies explain that this is mainly due to the immunosenescence of T and B cells, the immunosenescence of innate immunity can also be a significant contributing factor. Alterations in function, number, subset, and distribution of blood neutrophils, monocytes, and natural killer and dendritic cells are detected in aging, thus potentially reducing the efficacy of vaccines in older individuals. In this paper, we focus on t…

immunosenescenceSettore MED/04 - Patologia GeneraleVaccinationOrganic ChemistryagingGeneral MedicinevaccinesImmunity InnateCatalysisComputer Science ApplicationsInorganic Chemistrytrained immunityAdjuvants ImmunologicadjuvantsHumansimmunostimulationdendritic cellsPhysical and Theoretical ChemistryMolecular Biologyinnate immunitySpectroscopyAged
researchProduct

Classification of current anticancer immunotherapies.

2014

© 2014. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

immunostimulatory cytokinesmedicine.medical_treatmentReviewBioinformaticsDNA-based vaccinesEfficacy0302 clinical medicineCancer immunotherapyNeoplasmspeptide-based vaccines0303 health sciencesPatología//purl.org/becyt/ford/3.1 [https]CANCER3. Good healthMedicina BásicaOncologycheckpoint blockers030220 oncology & carcinogenesisQR180//purl.org/becyt/ford/3 [https]ImmunotherapyCIENCIAS MÉDICAS Y DE LA SALUDmedicine.drug_classInmunologíaadoptive cell transfer; checkpoint blockers; dendritic cell-based interventions; DNA-based vaccines; immunostimulatory cytokines; peptide-based vaccines; oncolytic viruses; Toll-like receptor agonistsMonoclonal antibodydendritic cell-based interventionsToll-like receptor agonistsRC025403 medical and health sciencesImmune systemAntigen[SDV.BBM] Life Sciences [q-bio]/Biochemistry Molecular BiologymedicineAnimalsHumans[SDV.BBM]Life Sciences [q-bio]/Biochemistry Molecular Biology[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular Biologyadoptive cell transfer030304 developmental biologyIMMUNOTHERAPIESbusiness.industryCancerImmunotherapymedicine.diseaseR1Oncolytic virusoncolytic virusesImmunologybusinessOncotarget
researchProduct

Non-specific Effects of Vaccines Illustrated Through the BCG Example: From Observations to Demonstrations

2018

Epidemiological studies regarding many successful vaccines suggest that vaccination may lead to a reduction in child mortality and morbidity worldwide, on a grander scale than is attributable to protection against the specific target diseases of these vaccines. These non-specific effects (NSEs) of the Bacille Calmette-Guérin (BCG) vaccine, for instance, implicate adaptive and innate immune mechanisms, with recent evidence suggesting that trained immunity might be a key instrument at play. Collectively referring to the memory-like characteristics of innate immune cells, trained immunity stems from epigenetic reprogramming that these innate immune cells undergo following exposure to a primary…

lcsh:Immunologic diseases. Allergy0301 basic medicinemedicine.medical_treatmentImmunologyReviewImmunity HeterologousWorld Health OrganizationEpigenesis Genetictrained immunity03 medical and health sciences0302 clinical medicineImmunityHumansTuberculosisImmunology and AllergyMedicineBCG030212 general & internal medicineEpigeneticsImmunity CellularInnate immune systemepigeneticsbusiness.industryVaccinationvaccinesMycobacterium bovisImmunity InnateChild mortalityVaccination030104 developmental biologyCell metabolismCytokinenon-specific effectsImmunologyBCG Vaccineepidemiologylcsh:RC581-607businessImmunologic MemoryReprogrammingFrontiers in Immunology
researchProduct

How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines

2015

In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity ofNeisseria meningitidisat a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology, immunology, and omics sciences (such as genomics and proteomics). Here, we review the molecular biology of the infectious agent and, in particular, its interactions with the immune system, focusing on both the innate and the adaptive responses. Meningococci exploit different mechanisms and complex machineries in order to subvert the immune system and to avoid being killed. Capsular polysaccharide and lipooligosaccharide glycan composition, in…

lcsh:Immunologic diseases. AllergyImmunologyGenomicsMeningococcal VaccinesMeningococcal vaccineReview ArticleBiologyMeningitis MeningococcalNeisseria meningitidisProteomicsmedicine.disease_causeImmune systemAntigenConjugate vaccineImmunityAnimals; Gram-Negative Bacteria; Host-Pathogen Interactions; Humans; Immunity; Meningitis Meningococcal; Meningococcal Vaccines; Neisseria meningitidis; Immune System; Immunology and Allergy; ImmunologyGram-Negative BacteriamedicineAnimalsHumansImmunology; Immunology and AllergyImmunology and AllergyNeisseria meningitidisImmunityGeneral MedicineVirologyImmune SystemHost-Pathogen Interactionslcsh:RC581-607
researchProduct

Antigen-specific T cells and cytokines detection as useful tool for understanding immunity against zoonotic infections.

2012

Zoonoses include a broad range of diseases, that are becoming of great interest, due to the climate changing, that cause the adaptation of vectors to new niches and environments. Host immune responses play a crucial role in determining the outcome of infections, as documented by expansion of antigen-specific T cells during several zoonotic infections. Thus, understanding of the contribution of antigen-specific T-cell subsets in the host immune response is a powerful tool to evaluate the different immunological mechanisms involved in zoonotic infections and for the development of effective vaccines. In this paper we discuss the role of T cells in some eukaryotic and prokaryotic infectious mo…

lcsh:Immunologic diseases. AllergyNematodaT-LymphocytesImmunologyReview ArticleAdaptive ImmunityBiologyHost-Parasite InteractionsImmune systemT-Lymphocyte SubsetsAntigen specificImmunityZoonosesAnimalsHumansImmunology and AllergyAntigensTh1-Th2 BalanceZoonoses antigen specific T-cells animal immunology.VaccinesBacteriaZoonotic InfectionGeneral MedicineAcquired immune systemVirologyImmunity InnateHost-Pathogen InteractionsImmunologyCytokinesAdaptationlcsh:RC581-607
researchProduct